Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
17 publications from 2014
O'Reilly MA, McHale C, Almazmi A, Hameed A, Benjamin D, O'Connell N, Murphy P, Quinn J, Thornton P, O'Gorman P, Frankova H, Sargent J, Verburgh E, McHugh J, Evans P, Enright H., A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy., Leukemia & lymphoma, 55, (12), 2014, p2950-2951
O'Reilly MA, McHale C, Almazmi A, Hameed A, Benjamin D, O'Connell N, Murphy P, Quinn J, Thornton P, O'Gorman P, Frankova H, Sargent J, Verburgh E, McHugh J, Evans P, Enright H., A 5-day: the favourable way?, Annals of hematology, 93, (9), 2014, p1619-1620
, Splenectomy-related red cell lysis resistance causing analytical difficulty in a patient with a hematological malignancy., Clinical laboratory, 2014
, Reaudit of Overnight Blood Transfusion in the Mater Misericordiae University Hospital (MMUH), IRISH JOURNAL OF MEDICAL SCIENCE, 2014
Orfali N., McKenna S.L., Cahill M.R., Gudas L.J., Mongan N.P., Retinoid receptor signaling and autophagy in acute promyelocytic leukemia, Experimental Cell Research, 324, (1), 2014, p1 - 12, p1-12
Conlon, N.P., Hayden, P., Barnes, L., Doran, M., O'Shea, F., Feigher, C., Schnitzler's syndrome; a case highlighting the complications of long-standing acquired autoinflammation, European Journal of Dermatology, 24, (3), 2014, p405-406
Gleeson, E.M. and O'Donnell, J.S. and Hams, E. and à inle, F.N. and Kenny, B.-A. and Fallon, P.G. and Preston, R.J.S., Activated factor x signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells, Haematologica, 99, (1), 2014, p185-193
Laffan, M.A. and Lester, W. and O'Donnell, J.S. and Will, A. and Tait, R.C. and Goodeve, A. and Millar, C.M. and Keeling, D.M. and Dolan, G., The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology, British Journal of Haematology, 167, (4), 2014, p453-465
Appleby N, Dillon A, Arrigan M, Fennell J, Crowley B, Hayden PJ, Enright H, Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma., Leukemia and Lymphoma, 55, (5), 2014, p1181 - 1183
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia., 2014
Laffan M, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling D , Diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organisation guideline approved by the British Committee for Standards in Haematology., British Journal of Haematology, 2014
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, Harbison JA, McCabe DJH, Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke., Journal of Neurology, 261, (7), 2014, p1405 - 1412
Matino D, Lillicrap D, Astermark J, Dolan G, Kessler C, Lambert T, Makris M, O'Donnell JS, Pipe S, Santagostino E, Saint-Remy, Iorio A., Switching clotting factor concentrates: Considerations in estimating the risk of immunogenicity., Haemophilia, 20, (2), 2014, p200 - 206
Gleason E, O'Donnell JS, Hams E, Fallon PF, Preston RJ. , Activated Factor X Inhibits Leukocyte Pro-inflammatory Cytokine Release upon Toll-like Receptor Stimulation. , Haematologica, 99, (1), 2014, p185 - 193
Lyons J, Vandenberghe E, Fahy R, McDonnell C, Keane J, McLaughlin AM, An unusual lung mass post stem cell transplantation., Transplant infectious disease : an official journal of the Transplantation Society, 16, (4), 2014, p672-675
Byrne CJ, Egan S, D'Arcy DM, O'Byrne P, Deasy E, Fennell JP, Enright H, McHugh J, Ryder SA, Teicoplanin usage in adult patients with haematological malignancy in the UK and Ireland: Is there scope for improvement, Eur J Hosp Pharm, 21, (5), 2014, p301 - 305
Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins RD, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ, Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups., European Journal of Neurology, 2014, p460-467